Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastomaOACSCD
Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma
Wei-Li Xu;Bao-Jun Shi;Suo-Lin Li;Feng-Xue Yu;Li-Na Guo;Meng Li;Zhi-Gang Hu;Gui-Xin Li;Hui Zhou
Department of Pediatric Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of Pediatric Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of Pediatric Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of Central Laboratory,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of Central Laboratory,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of Pediatric Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of General Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of General Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,ChinaDepartment of Pediatric Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,China
NeuroblastomaMyeloid-derived suppressor cellTumor microenvironmentDoxorubicinImmunotherapy
NeuroblastomaMyeloid-derived suppressor cellTumor microenvironmentDoxorubicinImmunotherapy
《中华医学杂志（英文版）》 2021 (3)
334-343,10
This study was supported by the grant from the National Natural Science Foundation of China(No.81472503).